CAS 6080-58-6|Trilithium citrate tetrahydrate
Introduction：Basic information about CAS 6080-58-6|Trilithium citrate tetrahydrate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Trilithium citrate tetrahydrate | ||
|---|---|---|---|
| CAS Number | 6080-58-6 | Molecular Weight | 281.984 |
| Density | / | Boiling Point | 309.6ºC at 760 mmHg |
| Molecular Formula | C6H13Li3O11 | Melting Point | 112 °C |
| MSDS | ChineseUSA | Flash Point | 155.2ºC |
Names
| Name | Citric acid, trilithium salt tetrahydrate |
|---|---|
| Synonym | More Synonyms |
Trilithium citrate tetrahydrate BiologicalActivity
| Description | Citric acid trilithium salt tetrahydrate is a pharmaceutical and construction material, used in HPLC gradient elution for quantitative amino acid analysis. |
|---|---|
| Related Catalog | Signaling Pathways >>Others >>OthersNatural Products >>Acids and AldehydesResearch Areas >>OthersBiochemical Assay Reagents |
Chemical & Physical Properties
| Boiling Point | 309.6ºC at 760 mmHg |
|---|---|
| Melting Point | 112 °C |
| Molecular Formula | C6H13Li3O11 |
| Molecular Weight | 281.984 |
| Flash Point | 155.2ºC |
| Exact Mass | 282.093811 |
| PSA | 177.54000 |
| InChIKey | HXGWMCJZLNWEBC-UHFFFAOYSA-K |
| SMILES | O.O.O.O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+] |
| Stability | Stable. Incompatible with strong oxidizing agents, reducing agents, bases. |
| Water Solubility | H2O: 1 M at 20 °C, clear, colorless |
Safety Information
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 1 |
Articles5
More Articles| Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography. J. Chromatogr. A. 613 , 223, (1993) A single-column gradient lithium ion-exchange chromatographic method with post-column derivatization and fluorimetric detection for the quantification of physiological amino acids is described. The me... | |
| Lithium citrate for Canavan disease. Pediatr. Neurol. 33 , 235-243, (2005) Current evidence suggests that the effects of lithium on metabolic and signaling pathways in the brain may vary depending on the specific clinical condition or disease model. For example, lithium incr... | |
| Lithium citrate as treatment of Canavan disease. Clin. Neuropharmacol. 35 , 150-151, (2012) Canavan disease is a rare autosomal recessive leukodystrophy characterized by abnormal accumulation of N-acetyl aspartate (NAA) in brain white matter. Currently, there is no cure for this disease, and... |
Synonyms
| Trilithium citrate tetrahydrate |
| Lithium 2-hydroxypropane-1,2,3-tricarboxylate hydrate (3:1:4) |
| citric acid trilithium salt tetrahydrate |
| EINECS 213-045-8 |
| MFCD00150030 |
| Lithium 2-hydroxy-1,2,3-propanetricarboxylate hydrate (3:1:4) |
| 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, lithium salt, hydrate (1:3:4) |
| LITHIUM CITRATE TETRAHYDRATE |
| Citric acid (trilithium salt tetrahydrate) |
